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1. Introduction 
N6-(A2 -Isopentenyl)-adenosine (IPA), a biolo- 
gically potent substance with cytokinin activity has 
been isolated from tRNA of a variety of plants, micro- 
organisms and mammalian tissues [ 11. Recent studies 
have demonstrated that IPA is able to inhibit blast 
transformation induced by phytohaemagglutin (PHA) 
in human and rat lymphocyte cultures. In addition, 
this substance inhibits the incorporation of 3H- 
uridine and 3 H-thymidine, respectively, in PHA- 
stimulated rat spleen cells and the immediate cut- 
aneous hypersensitivity in vivo [2]. In contrast, 
Braun and Nakano [3] have reported that IPA has no 
effect on plaque forming cells (PCF) in the spleens 
of mice immunized with sheep red blood cells (SRBC) 
and inhibits only the polyriboadenylic-polyribo- 
uridylic acid enhanced PFC-response to SRBC. 
It was therefore of interest to explore why IPA 
has no effect on the normal immune response to 
SRBC whereas it suppresses immediate hypersensi- 
tivity in vivo. The data presented in this paper show 
that IPA does inhibit 19 S hemolysin forming cell 
responses in mice immunized with optimal and 
suboptimal doses of SRBC. 3 H-Leucine and I4 C- 
uridine incorporation showed that IPA interferes 
with the mechanism of cellular RNA and protein 
synthesis in thymus cells but not in spleen cells 
from SRBC-immunized mice and also inhibits macro- 
phage migration. 
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2. Materials and methods 
2.1. Immunization of mice and IPA treatment 
4-5 week-old mice (NMRI/HAN) were inoculated 
with graded amounts of SRBC intraperitoneally. Other 
groups of mice were treated with IPA (100 mg/kg) 
given i.p. at various time intervals. 
2.2. Assay for 19 S hemolysin forming cells (PFC) 
Mice were killed 96 hr after immunization by de- 
capitation. Spleenic 19 S PFC response was deter- 
mined according to Jerne et al. [4]. For statistical 
analysis the Wilcoxon test [5] was used. 
2.3. 3H-Leucine and “C-uridine incorporation 
Thymus and spleen from non-immunized mice 
and immunized mice (2.0 X 10’ SRBC) were pooled 
separately. Thymus and portions of spleen were 
pooled in the same way from IPA treated immunized 
mice and cell suspensions prepared. 
Thymus tissue was teased with forceps and 
shaken for 1 hr at 4’ in Krebs-Henseleit-buffer of 
pH 7.4 (KHB) in order to prepare cell suspensions. 
Spleen cell suspensions in KHB were prepared by 
repeated withdrawal of teased spleen with a sterile 
plastic syringe and final filtration through a fine sieve. 
In both cases concentration was adjusted to 1 .O X 10’ 
cells/ml in KHB. To each 2 ml of thymus and spleen 
cell suspension 1 &i of 3 H-leucine and I4 C-uridine 
(The Radiochemical Centre, Amersham) were added 
separately. Incubation was continued for one hour 
at 3;“. The reaction was stopped by the addition of 
0.5 ml of 1% inactive leucine and uridine respectively 
and precipitation by 5% trichloroacetic acid (TCA) 
225 
Volume 15, number 3 FEBS LETTERS June 1971 
I 
z.r? z.loe 2m9 SRBC 
Fig. 1. Antigen dose dependent immunosuppressive effect of 
IPA. 100 mg/kg/day IPA treatment for seven days (three days 
before until1 three days after immunization); A, PFC/spleen in 
control group; fi, PFC/l.O X lo6 spleen cells in control group; 
l , k’FC/spleen i IPA treated group; 0, PFC/l.O X lo6 spleen 
cells in IPA treated group. 
final concentration). TCA-precipitable material was 
washed in each case three times after homogeniza- 
tion. The acid-insoluble material was then adjusted 
to 4 ml in 5% TCA and an aliquot was measured for 
3 H and 14C-cpm in Tri-CarbScintillation-Spectro- 
meter (Packard). The remaining sediment was used for 
RNA isolation and measurement [6,7]. Protein was 
determined according to Lowry et al. [8]. Radio- 
activity was measured in isolated fractions in order 
to express 14C-uridine/mg RNA and 3 H-leucine/mg 
protein. 
2.4. Macrophage migration 
The method used was similar to that described 
by David et al. [9] except that the peritoneal cell 
concentration before centrifugation of cells in 
capillary tubes (1.2 mm in diameter, 80 mm longj 
was 60 X 106/ml medium. The capacity of the Mac- 
kaness-type chambers was 1.25 ml. Control chambers 
contained only medium whereas other chambers were 
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filled with 1 to 1000 c(g IPA/ml medium. The area 
of migration was determined with a planimeter after 
48 hr incubation at 37”. 
3. Results and discussion 
When IPA (100 mg/kg) is given over a period of 
seven days it reduces the number of PFC per spleen 
and per 1 .O X IO6 nucleated spleen cells in mice 
immunized with SRBC. However, this effect could 
be demonstrated only at optimal (2.0 X lo*) and 
suboptimal (2.0 X 107) SRBC doses. IPA has no sig- 
nificant effect on PFC when mice are immunized 
with high antigen dose (fig. 1). 
Braun and Nakano [3] demonstrated that IPA 
has no effect on PFC-response measured 48 hr after 
the SRBC inoculation. This discrepancy may be due 
to the different experimental conditions (the antigen 
dose, the route of antigen inoculation, the time of 
IPA treatment and the time of assaying PFC-response) 
used by these authors. 
It is evident from the result presented here that 
immunosuppressive activity of IPA depends mainly 
upon the time of application in relation to the day 
of immunization (fig. 2). The PFC response to SRBC 
is only inhibited when IPA administration precedes 
antigen treatment. When IPA is given after immuni- 
zation no effect on the PFC response is noticed. How- 
ever, in both cases a significant involution of thymus 
without any alteration in the weight of spleen was ob- 
served. 
In our system IPA has no significant effect on the 
incorporation ?f 3 H-leucine and l4 C-uridine into 
protein and RNA of SRBC-stimulated spleen cells. 
However, IPA exerts a marked inhibitory effect on 
the incorporation of 3H-leucine and 14C-uridine 
in SRBC-stimulated thymus cells (table 1) so that 
IPA or its metabolites may exert their effect pri- 
marily on thymus-cell-mediated responses. In ad- 
dition, as evident from table 2 IPA also inhibits 
macrophage migration in vitro and a similar in vivo 
effect might diminish immunologically mediated 
inflammatory responses. 
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Fig. 2. Effect of timing of IPA treatment on PFC-response. Mice were immunized with 2.0 X IO’ SRBC. Figures in brackets refer 
to number of mice; (A) 100 mg/kg/day IPA treatment for seven days (three days before till three days after immunization);(B) 
100 mg/kg/day IPA treatment for four days (three days before and the day of immunization);(C) 100 mg/kg/day IPA treatment 
for four days (beginning on the day of immunization):#~fi~Control group. F IPA treated group. N.S., not significant; 
l .*.*.*.*_* 3B 
*p = 0.1; **p = 0.05; *** p = 0.02. 
Table 1 
Effect of IPA on ‘H-leucine and 14C-uridine incorporation in thymus and spleen cells of non-immunized, immunized and IPA 
treated immunized mice. 
Group Radioactivity (cpm) 
Thymus Spleen 
3H-Leucine/mg “C-Uridine/mg 3H-Leucine/mg r4C-Uridine/mg 
protein RNA protein RNA 
Control 1,090 9.250 1,225 4,970 
Immunized 4.410 23.800 1,652 14,340 
IPA treated 1,761 14,200 2,066 13,210 
and immunized 
Mice were immunized with 2.0 X 10’ SRBC. 
IPA treatment: 100 mg/kg i.p. for four days (three days before and the day of immunization). 
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Table 2 References 
Effect of IPA on macrophage migration. 
Substance 
(g/ml) 
Area of migration* 
(mm* f S.E.M.) 
% inhibition 
of migration 
Control 62.0 * 1.8 
IPA 
1 x 1o-6 
1 x 1o-5 
1 x 1o-4 
1 x 1o-3 
55.8 * 2.2 10.0 
47.0 f 2.3 24.2 
25.4 f 1.1 59.0 
complete inhibition 
* Areas of migration were measured by planimetry after 48 hr 
of incubation. 
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